Trial intelligence / Profile preview

Optimizing Peginterferon Alpha in CHB (I-Cure-3X)

NCT03801538Phase 4Unknown

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
Jan 2019
Primary completion
Dec 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.

02

Drugs

pegylated interferon alpha
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT03801538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03801538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call